O4 Hubs detail
O4 Detail Hero Banner
O4 1 Column (Full)
O4 2 Columns (1/4 - 3/4)
O4 Text Component

By 2023, U.S. drug spend is expected to reach up to $600 billion, with hundreds of high-cost, low-value drugs coming to market each year. Pharmacy plan sponsors can avoid unnecessary costs by spending pharmacy dollars on only the most clinically appropriate, cost-efficient medications.

Just like the state of New Jersey did.

"OptumRx has done a really great job in looking at our data and our trend and finding high-value opportunities. We're able to show our stakeholders that we are not making these changes to nickel and dime members and save $10 or $20 million here and there; we’re doing it to solve problems specific to our members." — Christin Deacon, Assistant Director of Pension and Benefits, State of New Jersey

O4 Text Component

Related Content

O4 Complex Card

Case study: $6M saved for long-term client

Continued collaboration results in additional savings.
O4 Complex Card

Drug pricing spotlight: Wound care

Combat against brand name products costing 125 times more.
O4 Complex Card

How to eliminate prescription waste

Achieve savings by targeting expensive, low-value drugs.

Learn how we can help solve your challenges

Related Content

O4 Complex Card

How new medication packaging helps the planet

New packaging saves CO2, water, energy, and plastic waste.
O4 Complex Card

Reality check: New drugs will cost more

The trend toward complex biologic drugs continues

O4 Complex Card

Forum: Pharmacy care without compromise

Addressing pharmacy issues that matter